Isoniazid resistance-conferring mutations are associated with highly variable phenotypic resistance
Background: High-dose isoniazid is recommended in the 9–12 months short-course regimen for multidrug-resistant tuberculosis with inhA mutation. However, there is insufficient evidence to support the assumption of genotypic-phenotypic concordance. This study aimed to identify the genetic mutations as...
保存先:
| 主要な著者: | , , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Elsevier
2023-12-01
|
| シリーズ: | Journal of Clinical Tuberculosis and Other Mycobacterial Diseases |
| 主題: | |
| オンライン･アクセス: | http://www.sciencedirect.com/science/article/pii/S2405579423000438 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|